Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Federal Trade Commission
US Army
Chubb
Cipla
Moodys
Harvard Business School
Daiichi Sankyo
Cerilliant

Generated: April 20, 2018

DrugPatentWatch Database Preview

Rifamycin Antimycobacterial Drug Class List

« Back to Dashboard

Drugs in Drug Class: Rifamycin Antimycobacterial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn MYCOBUTIN rifabutin CAPSULE;ORAL 050689-001 Dec 23, 1992 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us PRIFTIN rifapentine TABLET;ORAL 021024-001 Jun 22, 1998 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lupin Ltd RIFABUTIN rifabutin CAPSULE;ORAL 090033-001 Feb 24, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Deloitte
McKesson
Queensland Health
Argus Health
Fish and Richardson
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.